Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132606) titled 'OSCC serum biomarker' on Sept. 16.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine
Condition:
oral squamous cell carcinoma,OSCC
Intervention:
Gold Standard:Based on the pathology results
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-07-01
Target Sample Size: Target condition:500;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=336588
Published by HT Digital Content Services with pe...